The mitochondrial permeability transition (MPT) mediates hepatic necrosis after ischemia and reperfusion (I/R). Here, we studied the role of c-Jun N-terminal kinase 2 (JNK2) inMPT-induced liver injury. Wildtype (WT) and JNK2 knockout (KO) mice underwent 70 % liver ischemia for 1 hr followed by reperfusion for 8 hr, after which hepatocyte injury and animal survival was assessed. Compared withWT, JNK2KOmice had 38 % less alanine transaminase release and 39 % less necrosis by histology. Survival out to 14 days was also greater in JNK2KOmice (57 % vs. 11%), and overall Kaplan-Meier survival was improved. No difference in apoptosis was observed. Intravital multiphoton microscopy of potential-indicating rhodamine 123 after reperfusion revealed de...
Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling is one of the m...
Abstract Background and Aims: Hepatic ischemia–reperfusion injury (IRI) is the leading cause of earl...
For many inherited and acquired hepatic diseases, liver transplantation is the only possible therape...
Hemorrhagic shock leads to hepatic hypoperfusion and activation of mitogen-activated stress kinases ...
AbstractThe mechanism by which c-Jun N-terminal protein kinase (JNK) promotes tissue injury is poorl...
The mitochondrial permeability transition (MPT) plays an important role in hepatocyte death caused b...
Abstractc-Jun N-terminal kinase (JNK) is a stress-activated mitogen-activated protein kinase that pl...
AbstractBackground & Aims: Ischemia/reperfusion can initiate both necrotic and apoptotic death of he...
c-Jun N-terminal kinase (JNK), a stress-activated MAPK, is activated during cardiac ischemia-reperfu...
The molecular mechanisms underlying the initiation and control of the release of cytochrome c during...
NO and cGMP administered at reperfusion after ischaemia prevent injury to hepatocytes mediated by th...
Hepatic ischemia-reperfusion injury is a major cause of post-operative hepatic dysfunction and liver...
Abstract Background and aims: Hepatic ischemia-reperfusion injury (IRI) is the leading cause of ear...
AbstractA prolonged period of ischaemia followed by reperfusion irreversibly damages the heart. Such...
ABSTRACT—The earliest signaling pathways responsible for initiating the systemic response to hemorrh...
Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling is one of the m...
Abstract Background and Aims: Hepatic ischemia–reperfusion injury (IRI) is the leading cause of earl...
For many inherited and acquired hepatic diseases, liver transplantation is the only possible therape...
Hemorrhagic shock leads to hepatic hypoperfusion and activation of mitogen-activated stress kinases ...
AbstractThe mechanism by which c-Jun N-terminal protein kinase (JNK) promotes tissue injury is poorl...
The mitochondrial permeability transition (MPT) plays an important role in hepatocyte death caused b...
Abstractc-Jun N-terminal kinase (JNK) is a stress-activated mitogen-activated protein kinase that pl...
AbstractBackground & Aims: Ischemia/reperfusion can initiate both necrotic and apoptotic death of he...
c-Jun N-terminal kinase (JNK), a stress-activated MAPK, is activated during cardiac ischemia-reperfu...
The molecular mechanisms underlying the initiation and control of the release of cytochrome c during...
NO and cGMP administered at reperfusion after ischaemia prevent injury to hepatocytes mediated by th...
Hepatic ischemia-reperfusion injury is a major cause of post-operative hepatic dysfunction and liver...
Abstract Background and aims: Hepatic ischemia-reperfusion injury (IRI) is the leading cause of ear...
AbstractA prolonged period of ischaemia followed by reperfusion irreversibly damages the heart. Such...
ABSTRACT—The earliest signaling pathways responsible for initiating the systemic response to hemorrh...
Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling is one of the m...
Abstract Background and Aims: Hepatic ischemia–reperfusion injury (IRI) is the leading cause of earl...
For many inherited and acquired hepatic diseases, liver transplantation is the only possible therape...